Literature DB >> 2765364

Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissues.

R F Anderson1, K B Patel, K Reghebi, S A Hill.   

Abstract

The enzyme activities of endogenous xanthine dehydrogenase (XDH) and xanthine oxidase (XO) have been measured in 10 different types of mouse tumour and seven normal tissues. The conversion of XDH to XO has been observed in two tumour types upon the prolonged clamping off of the blood supply to the tumours. It is proposed that a similar conversion might also occur naturally in chronically hypoxic cells and that the ratio of the XO activity to the combined XO + XDH activities (%XO activity) could well serve as a marker for tissue hypoxia. A qualitative relationship exists between the %XO activity and literature values of the hypoxic fraction for some tumours measured by radiobiological assays. The influence of tumour size (about 0.2-1.8 g) on %XO activity is presented for all 10 tumours as well as %XO activity determinations for four of the normal tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2765364      PMCID: PMC2247042          DOI: 10.1038/bjc.1989.249

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo.

Authors:  J Denekamp; B D Michael; S R Harris
Journal:  Radiat Res       Date:  1974-10       Impact factor: 2.841

2.  Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.

Authors:  J Denekamp; S R Harris
Journal:  Radiat Res       Date:  1975-02       Impact factor: 2.841

3.  Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  1979-08       Impact factor: 3.039

4.  The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.

Authors:  B M Garrecht; J D Chapman
Journal:  Br J Radiol       Date:  1983-10       Impact factor: 3.039

5.  Vascular occlusion and tumour cell death.

Authors:  J Denekamp; S A Hill; B Hobson
Journal:  Eur J Cancer Clin Oncol       Date:  1983-02

6.  Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.

Authors:  M Horowitz; R Blasberg; P Molnar; J Strong; P Kornblith; R Pleasants; J Fenstermacher
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

7.  Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).

Authors:  N Prajda; H P Morris; G Weber
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

8.  Superoxide radicals in feline intestinal ischemia.

Authors:  D N Granger; G Rutili; J M McCord
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

9.  Xanthine oxidase type D (dehydrogenase) in the intestine and other organs of the rat.

Authors:  M G Battelli; E Della Corte; F Stirpe
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.766

10.  The histological structure of some human lung cancers and the possible implications for radiotherapy.

Authors:  R H THOMLINSON; L H GRAY
Journal:  Br J Cancer       Date:  1955-12       Impact factor: 7.640

View more
  6 in total

1.  Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.

Authors:  D L Gustafson; H D Beall; E M Bolton; D Ross; C A Waldren
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

2.  A gene signature-based approach identifies mTOR as a regulator of p73.

Authors:  Jennifer M Rosenbluth; Deborah J Mays; Maria F Pino; Luo Jia Tang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

3.  Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide.

Authors:  C S Parkins; A L Holder; S A Hill; D J Chaplin; G M Tozer
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

4.  Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis.

Authors:  Haixia Xu; Changlin Li; Olivier Mozziconacci; Runzhi Zhu; Ying Xu; Yuzhe Tang; Ruibao Chen; Yan Huang; Jeffrey M Holzbeierlein; Christian Schöneich; Jian Huang; Benyi Li
Journal:  Free Radic Biol Med       Date:  2019-05-16       Impact factor: 7.376

5.  Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiol.

Authors:  Sukirti Kalra; Gopabandhu Jena; Kulbhushan Tikoo; Anup Kumar Mukhopadhyay
Journal:  BMC Biochem       Date:  2007-05-18       Impact factor: 4.059

6.  Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection.

Authors:  R J Hodgkiss; G Jones; A Long; J Parrick; K A Smith; M R Stratford; G D Wilson
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.